Page last updated: 2024-11-02

phloretin and Parkinsonian Disorders

phloretin has been researched along with Parkinsonian Disorders in 1 studies

Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.

Research Excerpts

ExcerptRelevanceReference
"Neuroinflammation is one of the significant neuropathological conditions in Parkinson's disease (PD) which is due to microglial and astrocytes activation leads to progressive dopaminergic neuronal loss."1.51Phloretin attenuates behavior deficits and neuroinflammatory response in MPTP induced Parkinson's disease in mice. ( Liu, J; Yang, G; Zhang, G, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, G1
Yang, G1
Liu, J1

Other Studies

1 other study available for phloretin and Parkinsonian Disorders

ArticleYear
Phloretin attenuates behavior deficits and neuroinflammatory response in MPTP induced Parkinson's disease in mice.
    Life sciences, 2019, Sep-01, Volume: 232

    Topics: Animals; Behavior, Animal; Calcium-Binding Proteins; Cyclooxygenase 2; Cytokines; Disease Models, An

2019